Late Complications and Quality of Life Evaluation after Radiation Therapy for Long-Term Survivors of Nasopharyngeal Carcinoma
Y. Zhang,J. Yi,X. D. Huang,J. W. Luo,J. P. Xiao,S. Y. Li,G. Z. Xu,L. Gao
DOI: https://doi.org/10.1016/j.ijrobp.2015.07.1380
2015-01-01
Abstract:To analyze late complications and quality of life (QOL) among 5-year survivors of nasopharyngeal carcinoma treated with radiation therapy (RT). This cross-sectional analysis studied 100 consecutive long-term survivors of nasopharyngeal carcinoma who had previously undergone RT. All patients were clinically without evidence of recurrent disease and had at least 5 years of follow-up. Late complications were evaluated by CTCAE version 4.0. QOL was measured by the Short Form-36 (SF-36) physical and mental component scores and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Head and Neck 35-questions (EORTC-QLQ-H&N35). Complications and QOL between the different groups were analyzed with Mann-Whitney U and X2 tests. Tests were 2-tailed, and P≤.05 was considered as statistical significance. In the whole cohort, 67 patients (67.0%) were male, and 33 (33.0%) were female. The median age at diagnosis was 42 years (range, 14-76 years). Forty-two patients (42.0%) received cisplatin-based concurrent chemoradiation therapy, and the intensity modulated RT (IMRT) was given to 57 patients (57.0%). The radiation dosage ranged from 66 to 76 Gy (median 70 Gy). More than grade 2 subcutaneous fibrosis, xerostomia, smell dysfunction, and hear impairment occurred in 31 (31.0%), 11 (11.0%), 7 (7.0%), and 16 (16.0%) patients, respectively. Hypothyroidism, dental caries, injury of cranial nerve and brain injury were found in 65 (65.0%), 26 (26.0%), 12 (12.0%), and 7 (7.0%) patients, respectively. Of 24 patients responding to the QOL questionnaires, 12 (50.0%), 12 (50.0%), 7 (29.2%), 6 (25.0%), and 4 (16.7%) patients reported the “much or more” problems on swallow, teeth, saliva, smell, and sex, respectively. On the SF-36, the mean physical component score was 46.4 and the mean mental component score was 60. Patients receiving IMRT had significantly higher risk of hypothyroidism (77.2% vs 48.4%, P=.007), and lower risk of ≥grade 2 xerostomia (1.8% vs 23.3%, P=.008), ≥grade 2 subcutaneous fibrosis (21.1% vs 44.2%, P=.008) and trismus (7.0% vs 41.9%, P=.000). Differences were not found statistically significant on several other QOL scales. Our findings add to the body of literature that supports the acceptance of IMRT as standard treatment for nasopharyngeal carcinoma in favor of decreasing late complications, but the hypothyroidism should be cautioned. Most 5-year survivors were satisfied with their QOL points except the mouth problems.